An experimental drug has completely protected monkeys from lethal doses of a virus related to Ebola, bolstering confidence that a similar medicine might be effective if deployed in the current outbreak in Africa, researchers reported on Wednesday. The study demonstrates the “real-world utility of this technology,” said Thomas W. Geisbert, a professor of microbiology and immunology at UTMB and a senior author of the study, which is being published in Science Translational Medicine. He said more studies were being planned to determine whether the drug could be used even later. The news also appears in the Houston Chronicle, TIME Magazine, National Geographic, Bloomberg, U.S. News & World Report, Nature, International Business Times, Reuters, Los Angeles Times, Washington Post, USA Today and Voice of America.